Effect of ceruletide on epileptogenesis in amygdaloid kindled rats

Yoshitaka Yamamoto, Toshifumi Itano, Osamu Miyamoto, Masaaki Tokuda, Hideki Matsui, Najma A. Janjua, Hiroshi Suwaki, Yasushi Okada, Tetsuro Negi, Tetuhide H. Murakami, Osamu Hatase

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


The inhibitory effects of ceruletide (CLT), a cholecystokinin-8 (CCK)-like, peptide, were investigated in the epileptogenesis in the amygdaloid kindled rats. Lower doses of CLT (20-80 μg/kg) inhibited the progression of kindling process. After acquiring C5 stage, a higher dose (160 μg.kg) was required to suppress the seizure susceptibility. These results, in light of several previous studies showing no serious side effects, suggest that CLT might be useful as an anti-epileptogenic agent for clinical usage.

Original languageEnglish
Pages (from-to)353-356
Number of pages4
JournalBrain Research
Issue number1-2
Publication statusPublished - Dec 10 1993


  • CCK
  • Ceruletide
  • Epilepsy
  • Kindling

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology


Dive into the research topics of 'Effect of ceruletide on epileptogenesis in amygdaloid kindled rats'. Together they form a unique fingerprint.

Cite this